首页> 美国卫生研究院文献>Gastroenterology and Hepatology From Bed to Bench >Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver
【2h】

Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver

机译:门静脉血栓形成导致正弦前非肝硬化门脉高压导致肝脏合成功能下降

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-cirrhotic portal hypertension (NCPH), defined as elevated portal pressures in the absence of cirrhosis, is a relatively rare cause of elevated portal pressures in western countries. In NCPH decompensated liver disease is common, but complications are often mitigated by appropriate medical therapy. Liver synthetic function loss is uncommon. We present a unique case of a patient with biopsy proven NCPH, who eventually developed progressive loss of hepatic synthetic function in the setting of long standing portal hypertension. This loss of synthetic function corresponded with the interval development of incomplete septal cirrhosis (ISC), and progression of previously noted nodular regenerative hyperplasia in biopsies performed 7 years apart. Our patient’s clinical course was complicated by multiple hospitalizations for gastrointestinal hemorrhage. Patients with ISC have higher rates of bleeding varices when compared to patients with macronodular cirrhosis. While patients with NCPH typically have better overall survival and fewer bleeding complications than cirrhotic patients, this is typically attributed to the former having preserved synthetic function. It appears that the presence of ISC may be a poor prognosticator in patients with NCPH.
机译:非肝硬化性门静脉高压症(NCPH)定义为在没有肝硬化的情况下门静脉压力升高,是西方国家门脉压力升高的相对罕见原因。在NCPH中,失代偿性肝病很常见,但通过适当的药物治疗通常可以减轻并发症。肝合成功能丧失很少见。我们提出了活检证实为NCPH的患者的独特案例,该患者最终在长期站立的门静脉高压症中发展为肝合成功能的进行性丧失。这种合成功能的丧失与不完全间隔性肝硬化(ISC)的间隔发展以及间隔7年的活检中先前提到的结节性再生增生的进展相对应。我们患者的临床过程因胃肠道出血多次住院而变得复杂。与大结节性肝硬化患者相比,ISC患者的静脉曲张发生率更高。尽管NCPH患者通常比肝硬化患者具有更好的总生存期和更少的出血并发症,但这通常归因于前者保留了合成功能。似乎ISC的存在可能对NCPH患者的预后不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号